氧驱动雾化方式吸入沐舒坦治疗婴幼儿哮喘急性发作期的临床价值

目的探讨氧驱动雾化方式吸入沐舒坦治疗婴幼儿哮喘急性发作期的效果。方法将广州市天河区妇幼保健院2010年2月～2011年10月收治的62例婴幼儿哮喘急性发作的患儿随机分为两组。对照组给予沐舒坦喷射雾化吸入,实验组给予氧驱动雾化方式吸入沐舒坦,观察比较两组患儿的治疗效果。结果实验组患儿治疗效果优于对照组患儿(P<0.05);实验组患儿咳嗽、哮喘的消失时间更快,与对照组患儿比较差异有统计学意义(P<0.05)。结论在婴幼儿哮喘急性发作期给予氧驱动雾化方式吸入沐舒坦的效果较好。

Objective To investigate the oxygen-driven atomization inhalation of ambroxol treatment of infantile asthma with acute exacerbation of the effect.Methods The patients were randomLy divided into two groups： 62 cases of infants and young children admitted to our hospital from February 2010 to October 2011 acute asthma attacks, the control group were given ambroxol jet aerosol inhalation, the experimental group, give oxygen atomizing inhalation the Mucosolvan observed and compared two groups of patient outcomes. Results The patient outcomes than the control group patients （P 〈 0.05）; experimental group patients cough, asthma disappeared faster time, a significant difference compared with the control group patients（P〈0.05）, statistically significant differences. Conclusion The acute exacerbation in infants and young children with asthma, give oxygen atomizing inhaled ambroxol better.